Vancomycin hydrochloride and Neoplasm progression - a phase IV clinical study of FDA data

Summary:

Neoplasm progression is reported as a side effect among people who take Vancomycin hydrochloride (vancomycin hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Gabapentin, and have Short-bowel syndrome.

The phase IV clinical study analyzes which people have Neoplasm progression when taking Vancomycin hydrochloride. It is created by eHealthMe based on reports of 8,214 people who have side effects when taking Vancomycin hydrochloride from the FDA, and is updated regularly.

What is Vancomycin hydrochloride?

Vancomycin hydrochloride has active ingredients of vancomycin hydrochloride. It is often used in mrsa infection. eHealthMe is studying from 8,399 Vancomycin hydrochloride users. Check the latest studies of Vancomycin hydrochloride.

What is Neoplasm progression?

Neoplasm progression (growth of tumour) is found to be associated with 1,065 drugs and 915 conditions by eHealthMe. Check the latest studies of Neoplasm progression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

8,214 people reported to have side effects when taking Vancomycin hydrochloride.
Among them, 27 people (0.33%) have Neoplasm progression.

Could Vancomycin hydrochloride cause Neoplasm progression?

Among these 27 people:

How long have people been on Vancomycin hydrochloride when they have Neoplasm progression? *

What is the gender of people who have Neoplasm progression when taking Vancomycin hydrochloride? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Neoplasm progression when taking Vancomycin hydrochloride? *

What are other drugs people take besides Vancomycin hydrochloride? *

Gabapentin: 7 people, 25.93%
Acetaminophen: 6 people, 22.22%
Sucralfate: 6 people, 22.22%
Fludrocortisone Acetate: 6 people, 22.22%
Carafate: 6 people, 22.22%
Prednisone: 6 people, 22.22%
Midodrine Hydrochloride: 6 people, 22.22%
Vfend: 5 people, 18.52%
Prolia: 4 people, 14.81%
Sertraline Hydrochloride: 4 people, 14.81%

What are other side effects people have besides Neoplasm progression? *

Weight Decreased: 10 people, 37.04%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 10 people, 37.04%
General Physical Health Deterioration (weak health status): 8 people, 29.63%
Diarrhea: 7 people, 25.93%
Abdominal Discomfort: 6 people, 22.22%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 22.22%
Herpes Zoster: 6 people, 22.22%
Mood Swings (an extreme or rapid change in mood): 6 people, 22.22%
Gastrointestinal Injury (injury to gastrointestinal tract): 6 people, 22.22%
Nausea (feeling of having an urge to vomit): 6 people, 22.22%

What are the existing conditions these people have? *

Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 6 people, 22.22%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 18.52%
Nausea (feeling of having an urge to vomit): 4 people, 14.81%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 14.81%
Acute Leukaemia (blood cancer): 4 people, 14.81%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 3 people, 11.11%
Intraocular Pressure Decreased: 3 people, 11.11%
Fungal Infection: 3 people, 11.11%
Headache (pain in head): 2 people, 7.41%
Glioma (a type of tumour that starts in the brain or spine): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin hydrochloride and have Neoplasm progression?

- Check whether Neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vancomycin hydrochloride:

Vancomycin hydrochloride (8,399 reports)

Browse all side effects of Vancomycin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm progression:

Neoplasm progression (1,065 drugs)

Browse all the conditions that are associated with Neoplasm progression:

Neoplasm progression (915 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vancomycin hydrochloride (the active ingredients of Vancomycin hydrochloride) and Vancomycin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.